Chai Discovery and Eli Lilly: A Strategic Partnership in Pharmaceutical AI Chai Discovery, an AI startup in the pharmaceutical sector, has signed a partnership with Eli Lilly, securing $130 million in funding and a $1.3 billion valuation.
AI and Rare Disease Treatment: A Revolution in Progress Find out how artificial intelligence is revolutionizing the treatment of rare diseases, tackling the shortage of skilled labor in the biotech sector.
Healthcare Digital Twins: Synthetic Data and AI in Medicine Digital twins of the human body promise to fill gaps in clinical data with synthetic models, physics-based simulation and predictive analysis.
Gene editing and beta-thalassaemia: first clinical results A new gene-editing approach shows clinical results in beta-thalassaemia, with greater precision, fewer errors and reduced dependence on transfusions.